Why is addressing the bacterial AMR threat so crucial to cancer care patient outcomes?
Immagine
Dr Najy Alsayed from the Menarini Group, a UICC partner, examines the growing threat of antimicrobial resistance for people with cancer, highlighting alarming global data, its clinical and economic impacts, and the urgent need for integrated surveillance, stewardship, and patient-centred care strategies.
Please feel free to use and promote the blog as you wish, if you just mention originally published on the UICC website with a link, that would be great.